Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection.

Zhi-Feng Xi,Seogsong Jeong,Chen-Chen Wang,Hong-Jie Li,Han Guo,Jie Cai,Jia-Xin Li,Xiao-Ni Kong,Ying Tong,Qiang Xia

Hepatobiliary & Pancreatic Diseases International（2019）

引用 9|浏览49

暂无评分

摘要

IL-26 is a novel prognostic factor for HCC after resection. Evaluation of IL-26 expression may be potentially valuable in clinical therapy when planning individualized follow-up schedule and evaluating candidates for prophylactic adjuvant treatment to prevent recurrence.

查看译文

关键词

Interleukin 26,Hepatocellular carcinoma,Surgical resection,Prognostic factors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要